(Q31863531)

4 July 2017

title

The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors (English)

1 reference

4 July 2017

Einat H

1

1 reference

4 July 2017

Clenet F

2

1 reference

4 July 2017

Shaldubina A

3

1 reference

4 July 2017

Belmaker RH

4

1 reference

4 July 2017

Bourin M

5

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Behavioural Brain Research

4 July 2017

published in

1 reference

4 July 2017

volume

118

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

77-83

1 reference

Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Physiopharmacological interactions between stress hormones and central serotonergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The effects of inositol treatment in animal models of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Rat brain monoamines after acute and chronic myo-inositol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Inositol reduces depressive-like behaviors in two different animal models of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Inositol treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Chronic dietary inositol enhances locomotor activity and brain inositol levels in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The anxiolytic effect of chronic inositol depends on the baseline level of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Controlled trials of inositol in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Lack of effect of inositol treatment in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Double-blind, controlled trial of inositol treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Inositol treatment of autism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Combination of inositol and serotonin reuptake inhibitors in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The Flinders sensitive line rats: a genetic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Clonidine potentiates the effects of 5-HT1A, 5-HT1B and 5-HT2A/2C antagonists and 8-OH-DPAT in the mouse forced swimming test.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

The validity of animal models of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900314-4

7 January 2021

10.1016/S0166-4328(00)00314-4

Identifiers

DOI

1 reference

4 July 2017

1 reference